Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities

International Journal of Cancer

Volumn 69, Issue 5, 1996, Pages 364-368

  Londesborough, Philip ^a   Linda, H O ^a   Terry, George ^a   Cuzick, Jack ^b   Wheeler, Cosette ^d   Singer, Albert ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c WHITTINGTON HOSPITAL   (United Kingdom)

^d UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; PAPILLOMA VIRUS; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA;

EID: 10544242964     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19961021)69:5<364::aid-ijc2>3.0.co;2-3     Document Type: Article

References (22)

1. BARTHOLOMEW, J.S., STACEY, S.N., COLES, B., BURT, D.J., ARRAND, J.R. and STERN, P.L., Identification of a naturally processed HLA A0201-restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein. Europ. J. Immunol., 24, 3175-3179 (1994).
2. BERGERON, C., FERENCZY, A., SHAH, K.V. and NAGHASHFAR, Z., Multicentric human papillomavirus infections of the female genital tract: correlation of viral types with abnormal mitotic figures, colposcopic presentation and location. Obstet. Gynecol., 69, 736-742 (1987).
3. BERNARD, H.-U., CHAN, S.-Y., MANOS, M.M., ONG, C.-K., VILLA, L.L., DELIUS, H., PEYTON, C.L., BAUER, H.M., and WHEELER, C.M., Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphism, nucleotide sequence and phylogenetic algorithms. J. infect. Dis., 170, 1077-1085 (1994).
4. CAMPION, M.J., MCCANCE, D.J., CUZICK, J. and SINGER, A., Progressive potential of mild cervical atypia: a colposcopic, cytological and virological study. Lancet, ii, 237-240 (1986).
5. COX, J.T., LORINCZ, A.T., SCHIFFMAN, M.H., SHERMAN, M.E., CULLEN, A. and KURMAN, R.J., Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Amer. J. Obstet. Gynecol., 172, 946-954 (1995).
6. CUZICK, J., SZAREWSKI, A., TERRY, G., HO, L., HANBY, A., MADDOX, P., ANDERSON, M., KOCJAN, G., STEELE, S.J. and GUILLEBAUD, J., HPV testing in primary cervical screening. Lancet, 345, 1533-1536 (1995).
7. CUZICK, J., TERRY, G., HO, L., HOLUNGWORTH, T. and ANDERSON, M., Human papillomavirus type 16 DNA in cervical smears as a predictor of high grade cervical intraepithelial neoplasia. Lancet, 339, 959-960 (1992).
8. CUZICK, J., TERRY, G., HO, L., HOLLINGWORTH, T. and ANDERSON, M., Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Brit. J. Cancer, 69, 167-171 (1994).
9. ELUS, J.R.M., KEATING, P.J., BAIRD, J., HOUNSELL, E.F., RENOUF, D.V., ROWE, M., HOPKINS, D., DUGGAN-KEEN, M.F., BARTHOLOMEW, J.S., YOUNG, L.S. and STERN, P.L., The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nature (Med.), 1, 464-470 (1995).
10. HILDESHEIM, A., SCHIFFMAN, M.H., GRAVITT, P.E., GLASS, A.G., GREER, C.E., ZHANG, T., SCOTT, D.R., RUSH, B.B., LAWLER, P., SHERMAN, M.E., KURMAN, R.J. and MANOS, M.M., Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis. 169, 235-240 (1994).
11. HO, G.Y.F., BURK, R.D., KLEIN, S., KADISH, A.S., CHANG, C.J., PALAN, P., BASU, J., TACHEZY, R., LEWIS, R. and ROMNEY, S., Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J. nat. Cancer Inst., 87, 1365-1371 (1995).
12. HO, L., TERRY, G., MANSELL, B., BUTLER, B. and SINGER, A., Detection of DNA and E7 transcripts of human papillomavirus types 16, 18, 31 and 33, TGF-β and GM-CSF transcripts in cervical cancers and precancers. Arch. Virol., 139, 79-85 (1995).
13. JENISON, S.A., YU, X.-P., VALENTINE, J.M. and GALLOWAY, D.A., Characterisation of human antibody-reactive epitopes encoded by human papillomavirus types 16 and 18. J. Virol., 65, 1208-1218 (1991).
14. LORINCZ, A.T., REID, R., JENSON, A.B., GREENBERG, M.D., LANCASTER, W. and KURMAN, R.J., Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol., 79, 328-337 (1992).
15. PARMENTER, C.A. and WHEELER, C.M., Nucleotide analysis of HPV types 16 and 31, E6/E7 regions. Abstract from the 12th International Papillomavirus Conference, p. 220 (1993).
16. REMMINK, A.J., WALBOOMERS, J.M.M., HELMERHORST, T.J.M., VOORHORST, F.J., ROZENDAAL, L., RISSE, E.K.J., MEIJER, C.J.L.M. and KENEMANS, P., The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int. J. Cancer, 61, 306-311 (1995).
17. STACEY, S.N., EKLUND, C., JORDAN, D., SMITH, N.K., STERN, P.L., DILLNER, J. and ARRAND, J.R., Scanning the structure and antigenicity of HPV-16 E6 and E7 oncoproteins using antipeptide antibodies. Oncogene, 9, 635-645 (1994).
18. SUN, X.-W., ELLERBROCK, T.V., LUNGU, O., CHIASSON, M.A., BUSH, T.J. and WRIGHT, T.C., Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet. Gynecol., 85, 680-686 (1995).
19. TERRY, G., HO, L., JENKINS, D., HILLS, M., SINGER, A., MANSELL, B. and BEVERLEY, E., Definition of human papillomavirus type 16 DNA levels in low and high grade cervical lesions by a simple polymerase chain reaction technique. Arch. Virol., 128, 123-133 (1992).
20. TERRY, G., HO, L., SZAREWSKI, A. and CUZICK, J., Semiautomated detection of human papillomavirus DNA of high and low oncogenic potential in cervical smears. Clin. Chem., 40/10, 1890-1892 (1994).
21. TING, Y. and MANOS, M.M., Detection and typing of genital human papillomavirus. In: M.A. Innis, D.H. Gelfond, J.J. Sninsky and T.J. White (eds.), PCR protocol: a guide to methods and applications, pp. 356-267, San Diego, CA: Academic Press (1990).
22. YAMADA, T., WHEELER, C.M., HALPERN, A.L., STEWART, A.-C.M., HILDESHEIM, A. and JENISON, S.A., Human papillomavirus type 16 variant lineages in United States populations characterised by nucleotide sequence analysis of the E6, L2 and L1 coding segments. J. Virol. 69, 7743-7753 (1995).